The etiology of oxidative stress in insulin resistance

Biomedical Journal

Volumn 40, Issue 5, 2017, Pages 257-262

  Hurrle, Samantha ^a   Hsu, Walter H ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Adipokines; Antioxidants; Insulin resistance; Obesity; Oxidative stress; Type 2 diabetes

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIOXIDANT; ASCORBIC ACID; FLAVONOID; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; REACTIVE OXYGEN METABOLITE; TOCOPHEROL;

ANTIOXIDANT ACTIVITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG TARGETING; HUMAN; INSULIN RESISTANCE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; CHEMISTRY; COMPLICATION; DRUG EFFECT; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANTIOXIDANTS; ASCORBIC ACID; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 85034440048     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bj.2017.06.007     Document Type: Short Survey

References (57)

1. Centers for Disease Control and Prevention, National diabetes statistics report: estimates of diabetes and its burden in the United States., 2014, HHS.
2. World Health Organization Media Centre, Global report on diabetes., 2016, WHO Press.
3. Aguilar, M., Bhuket, T., Torres, S., Liu, B., Wong, R., Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 313 (2015), 1973–1974.
4. Sies, H., The concept of oxidative stress after 30 years. Gelpi, R., Boveris, A., Poderoso, J., (eds.) Advances in biochemistry in health and disease, 2016, Springer, New York, 3–11.
5. Schrieber, M., Chandel, N., ROS function in redox signaling and oxidative stress. Curr Biol 24 (2014), 453–462.
6. Brand, M., Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med 100 (2016), 14–31.
7. Gao, C., Zhu, C., Zhao, Y., Chen, X., Ji, C., Zhang, C., et al. Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Mol Cell Endocrinol 320 (2010), 25–33.
8. Marinho, S., Real, C., Cyrne, L., Soares, H., Antunes, F., Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol 2 (2014), 535–562.
9. Dikalov, S., Cross talk between mitochondria and NADPH oxidases. Free Rad Biol Med 51 (2011), 1289–1301.
10. Hancer, N., Qiu, W., Cherella, C., Li, Y., Copps, K., White, M., Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. J Biol Chem 29 (2014), 12467–12484.
11. Cooper, G., The cell: a molecular approach. 7th ed., 2013, Sinauer, Massachusetts.
12. Blanco, C., McGill-Vargas, L., Gastaldelli, A., Seidner, S., McCurnin, D., Leland, M., et al. Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons. Endocrinology 156 (2015), 813–823.
13. Ma, J., Nakagawa, Y., Kojima, I., Shibata, H., Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes. J Biol Chem 298 (2013), 133–142.
14. Campa, C., Ciraolo, E., Ghigo, A., Germena, G., Hirsch, E., Crossroads of PI3K and rac pathways. Small GTPases 6 (2015), 71–80.
15. Henriksen, E., Diamond-Stanic, M., Marchionne, E., Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51 (2011), 993–999.
16. Tsai, H., Wang, W., Lin, C., Pai, P., Lai, T., Tsai, C., et al. NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK dependent activation of NF-kB in cardiomyocytes exposed to high glucose. J Cell Physiol 227 (2012), 1347–1357.
17. Al-Lahham, R., Deford, J., Papaconstantinou, J., Mitochondrial-generated ROS down regulates insulin signaling via activation of p38 MAPK stress response pathway. Mol Cell Endocrinol 419 (2015), 1–11.
18. Boucher, J., Kleinridders, A., Kahn, C., Insulin receptor signalling in normal and insulin resistant states. Cold Spring Harb Perspect Biol 6 (2014), 1–23.
19. Jheng, H., Tsai, P., Guo, S., Kuo, L., Chang, C., Su, I., et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 32 (2012), 309–319.
20. Paio, M., Kang, K., Lee, I., Kim, H., Kim, S., Choi, J., et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201 (2011), 92–100.
21. Matsuda, M., Shimomura, I., Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 7 (2013), 330–341.
22. Cohen, D., LeRoith, D., Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer 19 (2012), F27–F45.
23. Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R., Bugianesi, E., Gastaldelli, A., Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5 (2013), 1544–1560.
24. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A., Paquot, N., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105 (2014), 141–150.
25. Boden, G., Obesity, insulin resistance, and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18 (2011), 139–143.
26. Heinonen, S., Muniandy, M., Buzkova, J., Mardinoglu, A., Rodriguez, A., Fruhbeck, G., et al. Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins. Diabetologia 60 (2017), 169–181.
27. Salzano, S., Checconi, P., Hanschmann, E., Lillig, C., Bowler, L., Chan, P., et al. Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc Natl Acad Sci U S A 111 (2014), 12157–12162.
28. Lee, M., Wu, Y., Fried, S., Adipose tissue heterogeneity: implications of depot differences in adipose tissue for obesity complications. Mol Asp Med 34 (2013), 1–11.
29. Franceschi, C., Campisi, J., Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol 69 (2014), 4–9.
30. Barnes, M., Carson, M., Nair, M., Non-traditional cytokines: how catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine 72 (2015), 210–219.
31. Kizer, J., A tangled threesome: adiponectin, insulin sensitivity, and adiposity. Diabetes 62 (2013), 1007–1009.
32. Shehzad, A., Iqbal, W., Shehzad, O., Lee, Y., Adiponectin: regulation of its production and its role in human disease. Hormones 1 (2012), 8–20.
33. Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kubota, N., Kaneko, K., et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13 (2011), 401–412.
34. Adams, A., Kharitonenkov, A., FGF21 drives a shift in adipocytokine tone to restore metabolic health. Aging 15 (2013), 386–387.
35. Heredia, F., Gomez-Martinez, S., Marcos, A., Obesity, inflammation, and the immune system. Proc Nutr Soc 71 (2012), 332–338.
36. Matsuzawa, Y., The metabolic syndrome and adipocytokines. Expert Rev Clin Immunol 3 (2014), 39–46.
37. Shuster, A., Patlas, M., Pinthus, J., Mourtzakis, M., The clinical importance of visceral adiposity: a critical review for methods for visceral adipose tissue analysis. Br J Radiol 85 (2012), 1–10.
38. Reczek, C., Chandel, N., ROS-dependent signal transduction. Curr Opin Cell Biol 33 (2015), 8–13.
39. Halliwell, B., Gutteridge, J., Free radicals in biology and medicine. 5th ed., 2015, Oxford, United Kingdom.
40. Reece, J., Campbell, N., Cain, M., Urry, L., Wasserman, S., Minorsky, P., et al. Campbell biology. 10th ed., 2014, Cummings/Pearson, Massachusetts.
41. Pratt, C., Cornely, K., Essential biochemistry. 3rd ed., 2014, Wiley, New Jersey.
42. Sleiman, D., Al-Badri, M., Azar, S., Effect of Mediterranean diet in diabetes control and cardiovascular risk modification: a systematic review. Front Public Health, 3, 2015, 69.
43. Mason, S., Della Gatta, P., Snow, R., Russell, A., Wadley, G., Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with diabetes: findings of a randomized controlled study. Free Radic Biol Med 93 (2016), 227–238.
44. Etsuo, N., Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med 66 (2014), 3–12.
45. Ramezani, A., Djazayeri, A., Koohdani, F., Nematipour, E., Javanbakht, M., Keshavarz, S., et al. Omega-3 fatty acids/vitamin E behave synergistically on adiponectin receptor-1 and adiponectin receptor-2 gene expressions in peripheral blood mononuclear cell of coronary artery disease patients. Curr Top Nutraceutical Res 13 (2015), 23–32.
46. Li, D., Zhang, Y., Liu, Y., Sun, R., Xia, M., Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J Nutr 145 (2015), 742–748.
47. Suliburska, J., Bogdanski, P., Szulinska, M., Stepien, M., Pupek-Musialik, D., Jablecka, A., Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res 149 (2012), 315–322.
48. Ihm, S., Jang, S., Kim, O., Chang, K., Oak, M., Lee, J., et al. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis 224 (2012), 377–383.
49. Mann, J., Lonn, E., Yi, Q., Gerstein, H., Hoogwerf, B., Pogue, J., et al. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int 65 (2004), 1375–1380.
50. Lee, D., Folsom, A., Harnack, L., Halliwell, B., Jacobs, D., Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?. Am J Clin Nutr 80 (2004), 1194–1200.
51. Parrow, N., Leshin, J., Levine, M., Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal 19 (2013), 2141–2156.
52. Padayatty, S., Sun, H., Wang, Y., Riordan, H., Hewitt, S., Katz, A., et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 140 (2004), 533–537.
53. Borel, P., Desmarchelier, C., Nowicki, M., Bott, R., Tourniaire, F., Can genetic variability in α-tocopherol bioavailability explain the heterogenous response to a-tocopherol supplements?. Antioxid Redox Signal 22 (2014), 669–678.
54. Deng, C., Sun, Z., Tong, G., Yi, W., Ma, L., Zhao, B., et al. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway. PLoS One, 8, 2013, e58371.
55. Inman, D., Lambert, W., Calkins, D., Horner, P., α-Lipoic acid antioxidant treatment limits glaucoma retinal ganglion cell death and dysfunction. PLoS One, 8, 2013, e65389.
56. Liu, R., Health promoting components of fruits and vegetables in the diet. Adv Nutr 14 (2013), 3845–3925.
57. Ismail, H., Scapozza, L., Ruegg, U., Dorchies, O., Diapocynin, a dimer of NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic muscle. PLoS Med 9 (2014), 1–8.